Friday, 4 April 2025
27.2 C
Singapore
30.2 C
Thailand
20.3 C
Indonesia
27.2 C
Philippines

Retro Biosciences, backed by Sam Altman, aims for US$1 billion to revolutionise ageing

Sam Altman backs Retro Biosciencesโ€™ US$1 billion raise to extend lifespan by 10 years, advance longevity technology, and target age-related diseases.

OpenAI CEO Sam Altman is ramping up his investment in Retro Biosciences, a San Francisco-based biotech company that aims to extend the healthy human lifespan by an additional 10 years. As reported by the Financial Times, the company is now raising US$1 billion in a Series A funding round, which Altman is supporting.

Building on a strong foundation

Altman had previously invested an impressive US$180 million in Retro Biosciencesโ€™ entire seed round. His continued backing reflects confidence in the companyโ€™s mission and potential. Retro Biosciences focuses on combating ageing-related diseases and advancing technologies to support longevity.

The startup has made significant strides in its research. Recently, it collaborated with OpenAI to train a model to transform ordinary cells into stem cells. These stem cells hold promise for treating various health conditions, including degenerative diseases like Alzheimerโ€™s.

Speaking to the Financial Times, Retro Biosciences CEO Joe Betts-LaCroix emphasised the urgency of their mission. He expressed a clear goal: to discover and develop a life-changing drug before the decade is over. “We want to move fast,” Betts-LaCroix said.

Billionaire-backed longevity movement

Retro Biosciences isnโ€™t alone in the race to extend human life. Several other billionaire-funded initiatives are working on similar goals. One of the most prominent examples is Altos Labs, launched in 2022 with US$3 billion in funding, backed by Amazon founder Jeff Bezos. Unity Biotechnology, another notable player in this space, has received support from Bezos and entrepreneur Peter Thiel.

These efforts highlight a growing interest in tackling the challenges of ageing and age-related diseases. The backing of tech visionaries and billionaires brings substantial financial resources and innovation to this emerging field.

With its ambitious goals and substantial financial support, Retro Biosciences is positioned as a key player in longevity. Its advancements in cell reprogramming and its determination to develop drugs targeting ageing-related diseases set it apart.

Altmanโ€™s financial commitment demonstrates his belief in the companyโ€™s vision and potential. As the biotech industry continues to explore groundbreaking ways to improve human health and extend life, Retro Biosciences will be watched to see if it can deliver on its promise to redefine healthy ageing in the years ahead.

Hot this week

Google’s Gemini 2.5 Pro AI model is now available for all users

Google's Gemini 2.5 Pro AI model is now available for all users, offering advanced coding and reasoning abilities with a free trial for Gemini Advanced.

Most APAC developers now view AI agents as vital to software development

Over four in five APAC developers believe AI agents are becoming as essential to app development as traditional software tools.

Samsung Galaxy A06 5G offers modern features at an affordable S$228

The Samsung Galaxy A06 5G, with a 50MP camera and 5,000mAh battery, launches in Singapore on March 21, 2025, for S$228.

Roblox introduces new parental controls to enhance child safety

Roblox introduces new parental controls, allowing parents to block games, restrict friends, and monitor their childโ€™s activity for better safety.

Intel remains on course for next-gen CPUs

Intel CEO Lip-Bu Tan confirms that next-gen CPUs, including Panther Lake and Nova Lake, remain on track, with Panther Lake arriving in 2025.

Spotify introduces AI-powered ads and programmatic ad buying

Spotify unveils AI-powered ads and the Spotify Ad Exchange, making it easier for advertisers to reach Gen Z listeners with real-time bidding.

YouTube expands shopping affiliate programme in Singapore through Shopee partnership

YouTube teams up with Shopee to launch its Shopping affiliate programme in Singapore, giving creators new ways to monetise their content.

Misconceptions about STEM careers continue to deter young women in Singapore

New research shows stereotypes and lack of support are deterring young women from STEM careers, posing a risk to Singaporeโ€™s innovation goals.

Synagie and HKT launch ShopHK to help Hong Kong brands expand into Southeast Asia

Synagie and HKT launch ShopHK, helping Hong Kong SMEs tap into Southeast Asia's booming US$600 billion e-commerce market.

Related Articles